English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

The controlled differentiation of embryonic stem cells into specific cell types holds promise for cell-based therapies in patients, including for the treatment of conditions affecting the heart. In recent years, the isolation of human embryonic stem cells (hESCs), the discovery of ‘induced pluripotency’ and, last but not least, the numerous studies in developing embryos, using model organisms, have brought us closer to the ultimate goal of generating cardiomyocytes in the dish.

WNT and BMP regulate roadblocks toward cardiomyocyte differentiation: lessons learned from embryos inform human stem cell differentiation